» Articles » PMID: 10485723

Will to Live in the Terminally Ill

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1999 Sep 15
PMID 10485723
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Complex biomedical and psychosocial considerations figure prominently in the debate about euthanasia and assisted suicide. No study to date, however, has examined the extent to which a dying patient's will to live fluctuates as death approaches.

Methods: This study examined patients with cancer in palliative care. Will to live was measured twice daily throughout the hospital stay on a self-report 100 mm visual analogue scale. This scale was incorporated into the Edmonton symptom assessment system, a series of visual analogue scales measuring pain, nausea, shortness of breath, appetite, drowsiness, depression, sense of well-being, anxiety, and activity. Maximum and median fluctuations in will-to-live ratings, separated by 12 h, 24 h, 7 days, and 30 days, were calculated for each patient.

Findings: Of 585 patients admitted to palliative care during the study period (November, 1993, to May, 1995), 168 (29%; aged 31-89 years) met criteria of cognitive and physical fitness and agreed to take part. The pattern of median changes in will-to-live score suggested that will to live was stable (median changes <10 mm on 100 mm scale for all time intervals). By contrast, the average maximum changes in will-to-live score were substantial (12 h 33.1 mm, 24 h 35.8 mm, 7 days 48.8 mm, 30 days 68.0 mm). In a series of stepwise regression models carried out at 12 h, 24 h, and 1-4 weeks after admission, the four main predictor variables of will to live were depression, anxiety, shortness of breath, and sense of well-being, with the prominence of these variables changing over time.

Interpretation: Among dying patients, will to live shows substantial fluctuation, with the explanation for these changes shifting as death approaches.

Citing Articles

Nursing Practices for Dyspnea Management in Patients with Cancer Based on Monthly and Weekly Prognoses: A Multi-Site Cross-Sectional Study of Palliative Care Nurses in Japan.

Kako J, Morikawa M, Kajiwara K, Kobayashi M, Kanno Y, Nakano K Palliat Med Rep. 2024; 5(1):440-444.

PMID: 39440109 PMC: 11491572. DOI: 10.1089/pmr.2024.0058.


Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.

Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y Cochrane Database Syst Rev. 2024; 9:CD015383.

PMID: 39260823 PMC: 11390284. DOI: 10.1002/14651858.CD015383.pub2.


Optimizing medication guidance support for patients with cancer pain: development and evaluation of a pharmaceutical care system for healthcare professionals.

Huang L, Zhang L, Huang H, Cai R, Yu H, Li J Support Care Cancer. 2024; 32(8):533.

PMID: 39037493 DOI: 10.1007/s00520-024-08738-2.


Older adults' attitudes toward using Euthanasia at the end-of life: cancer vs. Parkinson's disease.

Lifshitz R, Bachner Y, Carmel S Front Public Health. 2024; 12:1393535.

PMID: 38947343 PMC: 11211612. DOI: 10.3389/fpubh.2024.1393535.


User appraisal of a booklet for advance care planning in multiple sclerosis: a multicenter, qualitative Italian study.

Giordano A, De Panfilis L, Veronese S, Bruzzone M, Cascioli M, Farinotti M Neurol Sci. 2023; 45(3):1145-1154.

PMID: 37816932 PMC: 10858142. DOI: 10.1007/s10072-023-07087-y.